Article info

Download PDFPDF
Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease

Authors

  • Rafael Sanches dos Santos Postgraduate Program in Gynecology, Obstetrics and Mastology and PubMed articlesGoogle scholar articles
  • Juliana Maria Quinalha de Souza Postgraduate Program in Gynecology, Obstetrics and Mastology and Trophoblastic Diseases Center, Botucatu Medical School, UNESP–São Paulo State University, Botucatu, São Paulo; and PubMed articlesGoogle scholar articles
  • Antonio Braga Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Rio de Janeiro, Rio de Janeiro, Brazil; PubMed articlesGoogle scholar articles
  • Marcos Montanha Ramos Postgraduate Program in Gynecology, Obstetrics and Mastology and Trophoblastic Diseases Center, Botucatu Medical School, UNESP–São Paulo State University, Botucatu, São Paulo; and PubMed articlesGoogle scholar articles
  • Rafael Cortés-Charry Department of Obstetrics and Gynecology, GTD Unit, University Hospital of Caracas, Central University of Venezuela, Caracas, Venezuela; and PubMed articlesGoogle scholar articles
  • Izildinha Maestá Postgraduate Program in Gynecology, Obstetrics and Mastology and Trophoblastic Diseases Center, Botucatu Medical School, UNESP–São Paulo State University, Botucatu, São Paulo; and Department of Gynecology and Obstetrics, Botucatu Medical School, UNESP–São Paulo State University, Botucatu, São Paulo, Brazil. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Izildinha Maestá, MD, Department of Gynecology and Obstetrics, Botucatu Medical School, UNESP–São Paulo State University, Av. Prof. Montenegro s/n, Botucatu, São Paulo 18.618-970, Brazil. E-mail: imaesta{at}fmb.unesp.br.

Citation

Sanches dos Santos R, de Souza JMQ, Braga A, et al
Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease

Publication history

  • Received January 24, 2017
  • Accepted April 14, 2017
  • First published September 1, 2017.
Online issue publication 
January 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.